New Zealand markets close in 9 minutes

REGN Jan 2025 740.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
212.410.00 (0.00%)
As of 11:02AM EDT. Market open.
Full screen
Previous close212.41
Open212.41
Bid251.70
Ask260.00
Strike740.00
Expiry date2025-01-17
Day's range212.41 - 212.41
Contract rangeN/A
Volume1
Open interest17
  • Yahoo Finance

    Antitrust fervor is gripping Washington and Silicon Valley. But lawsuits have been declining.

    Antitrust lawsuits have declined since the pandemic despite a high-profile push by Washington to limit the concentration of power in key industries.

  • Reuters

    UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation

    Regeneron Pharmaceuticals said on Monday it seeks to defend against U.S. Department of Justice's complaint that alleged the company misreported the average sales price of its macular degeneration drug Eylea. "Reimbursing credit card service fees to distributors is not a price concession and does not affect EYLEA's price," Regeneron said in a statement, adding that it considered the complaint to be "meritless". The DOJ last week, in a complaint filed in federal court in Boston, alleged the drugmaker failed for years to report how it paid hundreds of millions of dollars to subsidize Eylea purchases by reimbursing drug distributors for credit-card processing fees.

  • Reuters

    Regeneron to defend against DOJ complaint on drug-price manipulation

    "Reimbursing credit card service fees to distributors is not a price concession and does not affect EYLEA's price," Regeneron said in a statement, adding that it considered the complaint to be "meritless". The DOJ last week, in a complaint filed in federal court in Boston, alleged the drugmaker failed for years to report how it paid hundreds of millions of dollars to subsidize Eylea purchases by reimbursing drug distributors for credit-card processing fees.